(Q38135314)

29 August 2017

0 references

The prognostic value of elevated ezrin in patients with osteosarcoma (English)

1 reference

29 August 2017

Deng-Xing Lun

1

1 reference

29 August 2017

Yong-Cheng Hu

2

1 reference

29 August 2017

Zhao-Wan Xu

3

1 reference

29 August 2017

Li-Na Xu

4

1 reference

29 August 2017

Bin-Wu Wang

5

1 reference

29 August 2017

publication date

7 September 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

35

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

1263-1266

1 reference

Stratifying osteosarcoma: minimizing and maximizing therapy.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Palliative therapy for osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

ERM proteins and merlin: integrators at the cell cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Clinical value of ezrin expression in primary osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Pulmonary cement embolism associated with percutaneous vertebroplasty or kyphoplasty: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Limoniastrum guyonianum aqueous gall extract induces apoptosis in human cervical cancer cells involving p16 INK4A re-expression related to UHRF1 and DNMT1 down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Clinical significance of NUCB2 mRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Ezrin mediates growth and survival in Ewing’s sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1168-2

Association between insulin receptor substrate 1 Gly972Arg polymorphism and cancer risk

21 January 2018

1 reference

12 December 2020

Effect of pregnancy and obesity on arch of foot

1 reference

12 December 2020

1 reference

12 December 2020

Bone delivers its energy information to fat and islets through osteocalcin

1 reference

12 December 2020

Ezrin expression predicts survival in stage IIB osteosarcomas

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials

1 reference

12 December 2020

Immunoexpression of Ezrin and CD44 in patients with osteosarcoma

1 reference

12 December 2020

10.1007/S13277-013-1168-2

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1016572479

0 references

1 reference